Drug categories M

Drug Category Names, Results, and Descriptions

.A • .B • .C • .D • .E • .F • . G • .H • I • .K • .L • .M • .N • .O • .P • .R • .S • .T • .U • .V • .W • #

• Membrane Transport Modulators  (275) • Agents that affect ION PUMPS; ION CHANNELS; ABC TRANSPORTERS; and other MEMBRANE TRANSPORT PROTEINS.

• Menstruation-Inducing Agents  (2) • Chemical compounds that induce menstruation either through direct action on the reproductive organs or through indirect action by relieving another condition of which amenorrhea is a secondary result. (From Dorland, 27th ed)

• Metabolic Side Effects of Drugs and Substances  (55)

• Metal Antagonists  (0) see Chelating Agents

• Metal Chelating Agents  (0) see Chelating Agents

• Microbicides  (0) see Anti-Infective Agents

• Microbicides, Topical  (0) see Anti-Infective Agents, Local

• Micronutrients  (92) • Essential dietary elements or organic compounds that are required in only small quantities for normal physiologic processes to occur.

• Mineralocorticoid Effect  (0) see Mineralocorticoids

• Mineralocorticoid Receptor Antagonists  (7) • Drugs that bind to and block the activation of MINERALOCORTICOID RECEPTORS by MINERALOCORTICOIDS such as ALDOSTERONE.

• Mineralocorticoid Synthesis Inhibitors  (0) see Steroid Synthesis Inhibitors

• Mineralocorticoids  (2) • A group of CORTICOSTEROIDS primarily associated with water and electrolyte balance. This is accomplished through the effect on ION TRANSPORT in renal tubules, resulting in retention of sodium and loss of potassium. Mineralocorticoid secretion is itself regulated by PLASMA VOLUME, serum potassium, and ANGIOTENSIN II.

• Miotic Effect  (0) see Miotics

• Miotics  (8) • Agents causing contraction of the pupil of the eye. Some sources use the term miotics only for the parasympathomimetics but any drug used to induce miosis is included here.

• Mitogens  (10) • Substances that stimulate mitosis and lymphocyte transformation. They include not only substances associated with LECTINS, but also substances from streptococci (associated with streptolysin S) and from strains of alpha-toxin-producing staphylococci. (Stedman, 25th ed)

• Mitosis Modulators  (45)

• Molecular Probes  (4)

• Molluscacides  (6) • Agents destructive to snails and other mollusks.

• Monoamine Oxidase Inhibitors  (37) • A chemically heterogeneous group of drugs that have in common the ability to block oxidative deamination of naturally occurring monoamines. (From Gilman, et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p414)

• Morning-After Pill  (0) see Contraceptives, Postcoital

• Mouthwashes  (6) • Solutions for rinsing the mouth, possessing cleansing, germicidal, or palliative properties. (From Boucher's Clinical Dental Terminology, 4th ed)

• Mucolytic Agents  (0) see Expectorants

• Muscarinic Agents  (0) see Cholinergic Agents

• Muscarinic Agonists  (11) • Drugs that bind to and activate muscarinic cholinergic receptors (RECEPTORS, MUSCARINIC). Muscarinic agonists are most commonly used when it is desirable to increase smooth muscle tone, especially in the GI tract, urinary bladder and the eye. They may also be used to reduce heart rate.

• Muscarinic Antagonists  (50) • Drugs that bind to but do not activate MUSCARINIC RECEPTORS, thereby blocking the actions of endogenous ACETYLCHOLINE or exogenous agonists. Muscarinic antagonists have widespread effects including actions on the iris and ciliary muscle of the eye, the heart and blood vessels, secretions of the respiratory tract, GI system, and salivary glands, GI motility, urinary bladder tone, and the central nervous system.

• Muscarinic Effect  (0) see Cholinergic Agents

• Muscle Relaxants, Central  (28) • A heterogeneous group of drugs used to produce muscle relaxation, excepting the neuromuscular blocking agents. They have their primary clinical and therapeutic uses in the treatment of muscle spasm and immobility associated with strains, sprains, and injuries of the back and, to a lesser degree, injuries to the neck. They have been used also for the treatment of a variety of clinical conditions that have in common only the presence of skeletal muscle hyperactivity, for example, the muscle spasms that can occur in MULTIPLE SCLEROSIS. (From Smith and Reynard, Textbook of Pharmacology, 1991, p358)

• Mutagens  (117) • Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes.

Drug Category Names, Results, and Descriptions

.A • .B • .C • .D • .E • .F • . G • .H • I • .K • .L • .M • .N • .O • .P • .R • .S • .T • .U • .V • .W • #

Comprehensive list of medications or pharmaceutical drugs used in the United States with their NDC or national drug code, brand name, dosage, forms of administration etc. sorted alphabetically.

• Top 200 drugs
• Medicare drugs
• Canadian drugs
• Dictionary of drugs
• Encyclopedia of drugs
• List of FDA approved drugs
• List of drugs A-Z - sorted in multipage format
• Drug categories
• Drug dosage forms
• Habit forming drugs

External links

The following is the collection of detailed information and links to the National Institute of Health (NIH) comprehensive drug information portal and other reliable sources of information. Select the drug name below to show drug description, drug classification, other common drug names, and information on the reasons why prescribed, how medication should be used, and what possible side effects could occur.

Drug names

A • B • C • D • E • F • G • H • I • J • K • L • M • N • O • P • Q • R • S • T • U • V • W • X • Y • Z

Search for other drug names not listed above